Baxter International Inc (BAX)
40.23
-0.70
(-1.71%)
USD |
NYSE |
Apr 25, 16:00
40.22
0.00 (0.00%)
After-Hours: 20:00
Baxter International Enterprise Value: 31.10B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | 31.10B |
April 24, 2024 | 31.46B |
April 23, 2024 | 31.50B |
April 22, 2024 | 31.19B |
April 19, 2024 | 30.71B |
April 18, 2024 | 30.81B |
April 17, 2024 | 30.74B |
April 16, 2024 | 30.76B |
April 15, 2024 | 31.00B |
April 12, 2024 | 31.15B |
April 11, 2024 | 32.06B |
April 10, 2024 | 32.00B |
April 09, 2024 | 32.42B |
April 08, 2024 | 32.13B |
April 05, 2024 | 32.31B |
April 04, 2024 | 32.32B |
April 03, 2024 | 32.65B |
April 02, 2024 | 32.46B |
April 01, 2024 | 32.79B |
March 28, 2024 | 32.37B |
March 27, 2024 | 32.35B |
March 26, 2024 | 31.77B |
March 25, 2024 | 31.89B |
March 22, 2024 | 31.97B |
March 21, 2024 | 32.00B |
Date | Value |
---|---|
March 20, 2024 | 31.91B |
March 19, 2024 | 31.97B |
March 18, 2024 | 31.77B |
March 15, 2024 | 31.80B |
March 14, 2024 | 32.01B |
March 13, 2024 | 32.34B |
March 12, 2024 | 32.45B |
March 11, 2024 | 32.75B |
March 08, 2024 | 32.90B |
March 07, 2024 | 32.76B |
March 06, 2024 | 32.50B |
March 05, 2024 | 32.21B |
March 04, 2024 | 32.25B |
March 01, 2024 | 31.50B |
February 29, 2024 | 31.45B |
February 28, 2024 | 31.78B |
February 27, 2024 | 31.92B |
February 26, 2024 | 32.00B |
February 23, 2024 | 32.28B |
February 22, 2024 | 32.00B |
February 21, 2024 | 32.12B |
February 20, 2024 | 31.88B |
February 16, 2024 | 31.60B |
February 15, 2024 | 31.46B |
February 14, 2024 | 30.80B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
26.86B
Minimum
Oct 12 2023
59.68B
Maximum
Feb 09 2022
42.36B
Average
43.23B
Median
Oct 05 2021
Enterprise Value Benchmarks
Becton Dickinson & Co | 81.51B |
LeMaitre Vascular Inc | 1.302B |
Integer Holdings Corp | 4.649B |
Outset Medical Inc | 46.99M |
Perspective Therapeutics Inc | 931.55M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 245.00M |
Revenue (Quarterly) | 3.885B |
Total Expenses (Quarterly) | 3.52B |
EPS Diluted (Quarterly) | 0.48 |
Gross Profit Margin (Quarterly) | 37.89% |
Profit Margin (Quarterly) | 6.31% |
Earnings Yield | 12.98% |
Operating Earnings Yield | 2.30% |
Normalized Earnings Yield | 0.1743 |